We are seeing a massive structural shift. With the market projected to climb from $6.56 Billion in 2024 to $9.80 Billion by 2032, the window for "business as usual" is closing. In a sector where a single purity deviation or supply delay can halt a multi-billion dollar production line, traditional market research is a liability, not an asset. https://www.databridgemarketresearch.com/nucleus/global-pharmaceutical-solvent-market